Items where Author is "Deng, Shanshan"
 | Up a level |
Article
Cui, Guofei and Zhou, Yi and Liao, Weiting and Cossu, Eleonora and Evert, Matthias and Zhang, Shu and Wang, Jingxiao and Deng, Shanshan and Yonemura, Andrew and David, Lucie and Xu, Meng and Doumergue, Juliette M. and Lu, Xinjun and Yang, Lihui and Li, Jinghua and Liang, Binyong and Wang, Haichuan and Xu, Hongwei and Zhong, Sheng and Deng, Youping and Calvisi, Diego F. and Zhao, Jinqiu and Chen, Xin and Wang, Xue (2025) Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma. CANCER RESEARCH, 85 (24). pp. 5049-5065. ISSN 0008-5472, 1538-7445
Deng, Shanshan and Lu, Xinjun and Wang, Xue and Liang, Binyong and Xu, Hongwei and Yang, Doris and Cui, Guofei and Yonemura, Andrew and Paine, Honor and Zhou, Yi and Zhang, Yi and Simile, Maria Maddalena and Urigo, Francesco and Evert, Matthias and Calvisi, Diego F. and Green, Benjamin L. and Chen, Xinrui (2024) Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma. CELL DEATH & DISEASE, 15 (6): 441. ISSN 2041-4889,
Zhou, Yi and Zhang, Shu and Qiu, Guoteng and Wang, Xue and Yonemura, Andrew and Xu, Hongwei and Cui, Guofei and Deng, Shanshan and Chun, Joanne and Chen, Nianyong and Xu, Meng and Song, Xinhua and Wang, Jingwen and Xu, Zijing and Deng, Youping and Evert, Matthias and Calvisi, Diego F. and Lin, Shumei and Wang, Haichuan and Chen, Xin (2024) TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC-induced murine hepatocarcinogenesis via centromere protein M. JOURNAL OF CLINICAL INVESTIGATION, 134 (22): e174415. ISSN 0021-9738, 1558-8238
Lu, Xinjun and Deng, Shanshan and Xu, Jiejie and Green, Benjamin L. and Zhang, Honghua and Cui, Guofei and Zhou, Yi and Zhang, Yi and Xu, Hongwei and Zhang, Fapeng and Mao, Rui and Zhong, Sheng and Cramer, Thorsten and Evert, Matthias and Calvisi, Diego F. and He, Yukai and Liu, Chao and Chen, Xintong (2023) Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models. JOURNAL OF CLINICAL INVESTIGATION, 133 (11): e163291. ISSN 0021-9738, 1558-8238
Deng, Shanshan and Solinas, Antonio and Calvisi, Diego F. (2021) Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models. FRONTIERS IN ONCOLOGY, 11: 756672. ISSN 2234-943X
